Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1768313 | 0.83 | KCNN4 (0.41) | TTRCA1CA2CA7CA9 | |
| SCHEMBL19971952 | 0.83 | TTR (0.44) | TTRACHEPDK2NFE2L2NPC1 | |
| SCHEMBL18939793 | 0.83 | TTR (0.35) | TTRCES2CES1CA1CA2 | |
| SCHEMBL18938476 | 0.81 | TTR (0.34) | TTRKCNN4NPC1RAB9ALMNA | |
| SCHEMBL20721741 | 0.77 | TDP2 (0.39) | TDP2TAAR1 | |
| SCHEMBL935455 | 0.77 | — | — | |
| SCHEMBL29673107 | 0.77 | — | — | |
| SCHEMBL8985713 | 0.77 | — | — | |
| SCHEMBL12683 | 0.75 | — | — | |
| SCHEMBL30670992 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-11780831-B2 | Compound, display panel and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024511-A1 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | C1S, DRD1, DRD3 | TTR 3898/4885CES2 668/4885CES1 1316/4885 |
| US-11780831-B2 | Compound, display panel and display apparatus | C1S, DRD1, DRD3 | TTR 3898/4885CES2 668/4885CES1 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.